https://thebostonexaminer.com/article/903375790-opco-laboratory-launches-new-website-and-rebrand-to-showcase-advanced-optical-engineering-capabilities The Boston Examiner en PressRelease 2026-04-03T13:30:00+00:00 OPCO Laboratory Launches New Website and Rebrand to Showcase Advanced Optical Engineering Capabilities https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824984-opco-solutions-website-1250x1242.png https://thebostonexaminer.com/article/903380241-trialt-and-viedoc-partner-to-deliver-smarter-faster-clinical-trial-outcomes-through-connected-data-and-biometrics The Boston Examiner en PressRelease 2026-04-03T13:00:00+00:00 Trialt and Viedoc Partner to Deliver Smarter, Faster Clinical Trial Outcomes Through Connected Data and Biometrics https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825013-trialt-and-viedoc-partner-logos-664x121.png https://thebostonexaminer.com/article/903541829-debut-arctic-thriller-thrymsa-arrives-as-real-world-competition-for-the-high-north-intensifies The Boston Examiner en PressRelease 2026-04-03T12:41:51+00:00 Debut Arctic Thriller THRYMSA Arrives as Real-World Competition for the High North Intensifies https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825619-thrymsa-cover-2400x2400.jpeg https://thebostonexaminer.com/article/903535953-influential-women-highlights-leslie-credle-founder-and-executive-director-of-justice-for-housing-j4h The Boston Examiner en PressRelease 2026-04-03T11:58:21+00:00 Influential Women Highlights Leslie Credle: Founder and Executive Director of Justice for Housing (J4H) https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825600-leslie-credle-390x482.png https://thebostonexaminer.com/article/903555236-rhythm-pharmaceuticals-announces-changes-to-board-of-directors The Boston Examiner en PressRelease 2026-04-03T13:00:00+00:00 Rhythm Pharmaceuticals Announces Changes to Board of Directors https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://thebostonexaminer.com/article/903554922-bicara-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-03T12:30:00+00:00 Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://thebostonexaminer.com/article/903386542-from-campus-to-community-rednote-inspires-a-new-generation-of-creators-across-north-america The Boston Examiner en PressRelease 2026-04-02T19:06:26+00:00 From Campus to Community: Rednote Inspires a New Generation of Creators Across North America https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824156-rn1-2364x1687.jpeg https://thebostonexaminer.com/article/903386545-financial-times-ranks-gray-gray-gray-among-fastest-growing-companies-in-the-americas The Boston Examiner en PressRelease 2026-04-02T19:01:45+00:00 Financial Times Ranks Gray, Gray & Gray Among Fastest Growing Companies in the Americas https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/721471-gray-gray-gray-logo-1280x1024.jpeg https://thebostonexaminer.com/article/902973320-q2i-named-healthtech-company-of-the-year-advancing-contingency-management-nationwide The Boston Examiner en PressRelease 2026-04-02T14:45:00+00:00 Q2i Named HealthTech Company of the Year, Advancing Contingency Management Nationwide https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24822518-addiction-freedom-2121x1414.jpeg https://thebostonexaminer.com/article/903302002-gai-insights-secures-500-000-pre-seed-round-to-scale-its-ai-navigator-platform-for-financial-and-enterprise-markets The Boston Examiner en PressRelease 2026-04-02T13:04:00+00:00 GAI Insights Secures $500,000 Pre-Seed Round to Scale Its AI Navigator Platform for Financial and Enterprise Markets https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824491-gaiinsightspreseedfunding-1079x1071.jpeg https://thebostonexaminer.com/article/903328416-censinet-launches-ai-grc-webinar-series-featuring-leading-healthcare-cybersecurity-and-ai-governance-experts The Boston Examiner en PressRelease 2026-04-02T12:41:00+00:00 Censinet Launches AI GRC Webinar Series Featuring Leading Healthcare Cybersecurity and AI Governance Experts https://thebostonexaminer.com/article/903418769-relay-therapeutics-to-present-initial-clinical-data-on-zovegalisib-in-vascular-anomalies-at-the-international-society-for-the-study-of-vascular The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://thebostonexaminer.com/article/903418840-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://thebostonexaminer.com/article/903418845-minerva-announces-leadership-transition The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Minerva Announces Leadership Transition https://ml.globenewswire.com/media/69e604cb-25b6-4235-ae9a-17c25cc158b9/small/minerva-logo.jpg https://thebostonexaminer.com/article/903419076-akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-02T20:05:00+00:00 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://thebostonexaminer.com/article/903399500-praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-02T20:01:00+00:00 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://thebostonexaminer.com/article/903399638-vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid The Boston Examiner en PressRelease 2026-04-02T18:40:00+00:00 Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid https://ml.globenewswire.com/media/6a144258-8523-493f-8a1e-ccceec233208/small/vericel-corporation-logo.jpg https://thebostonexaminer.com/article/903159949-gander-robotics-closes-1-1m-pre-seed-round-to-build-autonomous-search-and-rescue-robots The Boston Examiner en PressRelease 2026-04-02T04:55:43+00:00 Gander Robotics Closes $1.1M Pre-Seed Round to Build Autonomous Search and Rescue Robots https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24823620-michael-checks-2000x1333.jpeg https://thebostonexaminer.com/article/902591627-nipes-announces-winners-of-the-2026-award-of-excellence-first-cycle The Boston Examiner en PressRelease 2026-04-02T04:33:47+00:00 NIPES Announces Winners of the 2026 Award of Excellence, First Cycle https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23021436-nipes-1403x653.png https://thebostonexaminer.com/article/903364191-advent-technologies-enters-into-license-and-joint-development-agreement-with-eh-group-engineering-ag-to-advance-htpem-fuel-cell-technology-for The Boston Examiner en PressRelease 2026-04-02T14:33:02+00:00 Advent Technologies Enters into License and Joint Development Agreement with EH Group Engineering AG to Advance HTPEM Fuel Cell Technology for Stationary Power Applications https://ml.globenewswire.com/media/e7558df7-45a6-41c9-8284-5e53d7bf13b6/small/advent-logo-png.png https://thebostonexaminer.com/article/903360663-beacon-hill-appoints-tim-barber-to-lead-finance-accounting-in-charlotte The Boston Examiner en PressRelease 2026-04-02T14:01:00+00:00 Beacon Hill Appoints Tim Barber to Lead Finance & Accounting in Charlotte https://ml.globenewswire.com/media/YTVhNmI1MjMtMjRlMS00Yzg1LTgxYjQtMDU4YTIwY2RiMmNiLTUwMDEyNjM2MS0yMDI2LTA0LTAyLWVu/tiny/Beacon-Hill.png https://thebostonexaminer.com/article/903344419-global-flexible-pcb-market-to-nearly-double-reaching-41-7-billion-by-2030-on-surging-demand-from-consumer-electronics-evs-and-5g-infrastructure The Boston Examiner en PressRelease 2026-04-02T13:06:30+00:00 Global Flexible PCB Market to Nearly Double, Reaching $41.7 Billion by 2030 on Surging Demand from Consumer Electronics, EVs and 5G Infrastructure https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://thebostonexaminer.com/article/903342608-sun-cruiser-expands-offerings-with-new-category-innovation-white-tea-vodka The Boston Examiner en PressRelease 2026-04-02T13:01:00+00:00 Sun Cruiser Expands Offerings with New Category Innovation: White Tea + Vodka https://ml.globenewswire.com/media/MmM0MzAxMjYtNjVmYi00M2IxLWE2MmQtZDgxYTA3NGY1M2QwLTEzMDA4NDQtMjAyNi0wNC0wMi1lbg==/tiny/Sun-Cruiser-Iced-Tea-Vodka.png https://thebostonexaminer.com/article/903342195-quickbase-acquires-solvice The Boston Examiner en PressRelease 2026-04-02T13:00:00+00:00 Quickbase Acquires Solvice https://ml.globenewswire.com/media/348bbc98-87d0-4dbd-8ee3-749e93775583/small/quickbase-logo-fullcolor-dune-png.png https://thebostonexaminer.com/article/903341867-l3harris-selects-mercury-to-provide-solid-state-data-recorders-for-sda-s-tranche-3-tracking-layer-satellites The Boston Examiner en PressRelease 2026-04-02T11:00:00+00:00 L3Harris Selects Mercury To Provide Solid-State Data Recorders for SDA’s Tranche 3 Tracking Layer Satellites https://ml.globenewswire.com/media/f1ffd4fb-997f-4591-b49c-746ac6927d1e/medium/tranche-3-tracking-layer.png https://thebostonexaminer.com/article/903342871-neutrolis-announces-positive-first-in-human-phase-1a-results-from-liberate-i-trial-of-ntr-1011-a-first-in-class-dnase1l3-fusion-protein The Boston Examiner en PressRelease 2026-04-02T11:00:00+00:00 Neutrolis Announces Positive First-in-Human Phase 1a Results from LIBERATE-I Trial of NTR-1011, a First-in-Class DNASE1L3 Fusion Protein https://ml.globenewswire.com/media/44cdba09-fdb9-4ee1-b7bf-1dcfe5784800/small/20180228-opr-or-logos-biz-wd-neutrolis-logo-1-jpg.jpg https://thebostonexaminer.com/article/903321680-tnqtech-a-lumina-datamatics-company-certified-as-a-great-place-to-work The Boston Examiner en PressRelease 2026-04-02T09:05:59+00:00 TNQTech, a Lumina Datamatics Company, Certified as a Great Place to Work® https://ml.globenewswire.com/media/cc092f47-3063-4df1-97c8-d586c8e5ad24/small/lumina-datamatics-logo-with-trademark-and-registered-mark-jp.jpg https://thebostonexaminer.com/article/903151165-waterstone-properties-announces-sale-of-kidstreet-site-and-recapitalization-at-hanes-towne-village-in-winston-salem The Boston Examiner en PressRelease 2026-04-01T17:00:00+00:00 WATERSTONE PROPERTIES ANNOUNCES SALE OF KIDSTREET SITE AND RECAPITALIZATION AT HANES TOWNE VILLAGE IN WINSTON-SALEM https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24488893-waterstone-logo-mark-2664x3007.png https://thebostonexaminer.com/article/903151807-fair-housing-month-highlights-why-equal-treatment-still-matters-for-home-buyers The Boston Examiner en PressRelease 2026-04-01T14:56:46+00:00 Fair Housing Month Highlights Why Equal Treatment Still Matters for Home Buyers https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/20652662-buyers-brokers-only-logo-2400x510.png https://thebostonexaminer.com/article/903247534-celldex-announces-pricing-of-300-million-public-offering-of-common-stock The Boston Examiner en PressRelease 2026-04-02T01:48:19+00:00 Celldex Announces Pricing of $300 Million Public Offering of Common Stock https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://thebostonexaminer.com/article/903215210-beam-therapeutics-announces-publication-of-beacon-phase-1-2-data-for-risto-cel-in-patients-with-sickle-cell-disease-scd-in-the-new-england-journal The Boston Examiner en PressRelease 2026-04-01T21:12:19+00:00 Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://thebostonexaminer.com/article/903215040-vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-01T21:00:00+00:00 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://thebostonexaminer.com/article/903213976-x4-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-01T20:30:00+00:00 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9c8d99a6-5cb7-4826-ae93-6c84d7f84355/small/x4-logo-png.png https://thebostonexaminer.com/article/903197143-akebia-therapeutics-appoints-biopharmaceutical-leader-philip-vickers-ph-d-to-its-board-of-directors The Boston Examiner en PressRelease 2026-04-01T20:05:00+00:00 Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://thebostonexaminer.com/article/903197587-celldex-announces-proposed-public-offering-of-common-stock The Boston Examiner en PressRelease 2026-04-01T20:01:00+00:00 Celldex Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://thebostonexaminer.com/article/903181579-cloud-computing-in-cell-biology-genomics-and-drug-development-to-reach-15-6-billion-by-2030-as-biological-data-explosion-drives-demand The Boston Examiner en PressRelease 2026-04-01T17:47:07+00:00 Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png